MedTrace Logo

Differences Between Suicide Attempters and Suicide Ideators. Influence of the Brief Therapy Attempted Suicide Short Intervention Program (ASSIP) on Neuropsychological Correlates and Psychological Process Factors - Project 3

NCT06322199 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 119

Last updated 2026-01-23

No results posted yet for this study

Summary

The present study consists of 3 projects in total. It aims to investigate the (neuro-) psychological patterns from suicidal ideation to suicidal behavior as well as the feasibility and cost-effectiveness of ASSIP flex.

The overall aim of Project 3 is to evaluate the feasibility and cost-effectiveness of ASSIP flex over a 12-month follow-up period in terms of suicide reattempts and suicide correlates in a cohort who is attending ASSIP flex after a suicide attempt.

Conditions

  • Suicide, Attempted
  • Suicidal Ideation
  • Feasibility
  • Cost-effectiveness
  • Process Factors

Interventions

BEHAVIORAL

ASSIP (Attempted Suicide Short Intervention Program) flex

ASSIP is a specific therapy for patients after a suicide attempt. The brief therapy ASSIP consists of 3-4 sessions of approximately 50 min. each. ASSIP flex delivers ASSIP in the patient's personal environment as an outreach home treatment. The structure of the ASSIP is the same as in the regular ASSIP, but the program is delivered in the patient's environment. Session 1: A narrative interview is conducted, in which the patient is asked to tell her personal story, which led to the suicidal crisis. The narrative is video-recorded. Session 2: Using video playback of the recorded narrative, patient and therapist explore further details of the suicidal process. Session 3: A case conceptualization focusing on the patient's vulnerability and the trigger of the suicidal crisis is formulated in writing. A list of safety strategies for the prevention of future suicidal behavior is developed jointly with the patient. Regular letters are sent to patients over a period of 2 years.

Sponsors & Collaborators

  • University of Bern

    lead OTHER

Principal Investigators

  • Anja C. Gysin-Maillart, PD · Univerisity of Bern, University Hospital of Psychiatry, Translational Research Center

  • Adriana O. Frei, MSc · University of Bern, University Hospital of Psychiatry, Translational Research Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-23
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06322199 on ClinicalTrials.gov